Mucin

WikiDoc Resources for Mucin

Articles

Most recent articles on Mucin

Most cited articles on Mucin

Review articles on Mucin

Articles on Mucin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Mucin

Images of Mucin

Photos of Mucin

Podcasts & MP3s on Mucin

Videos on Mucin

Evidence Based Medicine

Cochrane Collaboration on Mucin

Bandolier on Mucin

TRIP on Mucin

Clinical Trials

Ongoing Trials on Mucin at Clinical Trials.gov

Trial results on Mucin

Clinical Trials on Mucin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Mucin

NICE Guidance on Mucin

NHS PRODIGY Guidance

FDA on Mucin

CDC on Mucin

Books

Books on Mucin

News

Mucin in the news

Be alerted to news on Mucin

News trends on Mucin

Commentary

Blogs on Mucin

Definitions

Definitions of Mucin

Patient Resources / Community

Patient resources on Mucin

Discussion groups on Mucin

Patient Handouts on Mucin

Directions to Hospitals Treating Mucin

Risk calculators and risk factors for Mucin

Healthcare Provider Resources

Symptoms of Mucin

Causes & Risk Factors for Mucin

Diagnostic studies for Mucin

Treatment of Mucin

Continuing Medical Education (CME)

CME Programs on Mucin

International

Mucin en Espanol

Mucin en Francais

Business

Mucin in the Marketplace

Patents on Mucin

Experimental / Informatics

List of terms related to Mucin

## Contents

* 1 Overview
* 2 Glycosylation and aggregation
* 3 Regions
* 4 Genes
* 5 Clinical significance
* 6 References
* 7 External links

## Overview

[edit | edit source]

Mucins are a family of large, heavily glycosylated proteins. Although some mucins are membrane-bound due to the presence of a hydrophobic membrane-spanning domain that favors retention in the plasma membrane, the concentration here is on those mucins that are secreted on mucosal surfaces and saliva.

## Glycosylation and aggregation

[edit | edit source]

Mucin genes encode mucin monomers that are synthesized as rod-shape apomucin cores that are post-translationally modified by exceptionally abundant glycosylation.

The dense "sugar coating" of mucins gives them considerable water-holding capacity and also makes them resistant to proteolysis, which may be important in maintaining mucosal barriers.

Mucins are secreted as massive aggregates of proteins with molecular masses of roughly 1 to 10 million Da. Within these aggregates, monomers are linked to one another mostly by non-covalent interactions, although intermolecular disulfide bonds may also play a role in this process.

## Regions

[edit | edit source]

Two distinctly different regions are found in mature mucins:

* The amino- and carboxy-terminal regions are very lightly glycosylated, but rich in cysteines, which are likely involved in establishing disulfide linkages within and among mucin monomers.

* A large central region formed of multiple tandem repeats of 10 to 80 residue sequences in which up to half of the amino acids are serine or threonine. This area becomes saturated with hundreds of O-linked oligosaccharides. N-linked oligosaccharides are also found on mucins, but much less abundantly.

## Genes

[edit | edit source]

At least 19 human mucin genes have been distinguished by cDNA cloning--MUC1, 2, 3A, 3B, 4, 5AC, 5B, 6-9, 11-13, and 15-19.

The major secreted airway mucins are MUC5AC and MUC5B, while MUC2 is secreted mostly in the intestine but also in the airway.

## Clinical significance

[edit | edit source]

Increased mucin production occurs in many adenocarcinomas, including cancer of the pancreas, lung, breast, ovary, colon, etc. Mucins are also overexpressed in lung diseases such as asthma, bronchitis, COPD or cystic fibrosis. Two membrane mucins, MUC1 and MUC4 have been extensively studied in relation to their pathological implication in the disease process. Moreover, mucins are also being investigated for their potential as diagnostic markers.

## References

[edit | edit source]

* Singh, A.P. et al. "Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis." Cancer Research 2004 Jan 15;64(2):622-30. [1]

* Ali, M.S., et al. "Major secretory mucin expression in chronic sinusitis." Otolaryngol Head Neck Surg. 2005 Sep; 133(3); 423-8. PMID: 16143194

* Perez-Vilar, J. and Hill, R. L. Mucin Family of Glycoproteins. Encyclopedia of Biological Chemistry (Lennarz & Lane, EDs.) Academic Press/Elsevier, Oxford, 2004, vol. 2, pp 758-764

* Singh, A.P. et al. "Aberrant expression of transmembrane mucins, MUC1 and MUC4, in human prostate carcinomas". Prostate. 2006 Mar 1;66(4):421-9. [2]

* Singh, A.P. et al. "Emerging roles of MUC4 in cancer: a novel target for diagnosis and therapy." Cancer Research 2007 Jan 15, 67(2):433-6. [3]

## External links

[edit | edit source]

* Mucins at the US National Library of Medicine Medical Subject Headings (MeSH)

* v
* t
* e

Protein, glycoconjugate: glycoproteins and glycopeptides

Mucoproteins|

| Mucin|

* CD43
* CD164
* MUC1
* MUC2
* MUC3A
* MUC3B
* MUC4
* MUC5AC
* MUC5B
* MUC6
* MUC7
* MUC8
* MUC12
* MUC13
* MUC15
* MUC16
* MUC17
* MUC19
* MUC20

|

Other|

* Haptoglobin
* Intrinsic factor
* Orosomucoid
* Peptidoglycan
* Phytohaemagglutinin
* Ovomucin

Proteoglycans|

| CS/DS|

* Decorin
* Biglycan
* Versican

|

HS/CS|

* Testican
* Perlecan

CS|

* Chondroitin sulfate proteoglycans: Aggrecan
* Neurocan
* Brevican
* CD44
* CSPG4
* CSPG5
* Platelet factor 4
* Structural maintenance of chromosomes 3

KS|

* Fibromodulin
* Lumican
* Keratocan

HS|

* Syndecan 1

Other|

* Activin and inhibin
* ADAM
* Alpha 1-antichymotrypsin
* Apolipoprotein H
* CD70
* Asialoglycoprotein
* Avidin
* B-cell activating factor
* 4-1BB ligand
* Cholesterylester transfer protein
* Clusterin
* Colony-stimulating factor
* Hemopexin
* Lactoferrin
* Membrane glycoproteins
* Myelin protein zero
* Osteonectin
* Protein C
* Protein S
* Serum amyloid P component
* Sialoglycoprotein
* CD43
* Glycophorin
* Glycophorin C
* Thrombopoietin
* Thyroglobulin
* Thyroxine-binding proteins
* Transcortin
* Tumor necrosis factor alpha
* Uteroglobin
* Vitronectin

Template:WH Template:WS Template:Jb1
*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template